Liaoning Oxiranchem Inc
Liaoning Oxiranchem,Inc. engages in the research and development, production, and sale of high-end and ethylene oxide derivative fine chemicals in China and internationally. The company offers crystalline silicon cutting liquids; water reducing agents polyether; polyether monomers and polyol; ethylene carbonate products; alcohol ether; dimethyl carbonate; alcohol amine polyether; and polyethylene… Read more
Liaoning Oxiranchem Inc (300082) - Total Liabilities
Latest total liabilities as of September 2025: CN¥2.60 Billion CNY
Based on the latest financial reports, Liaoning Oxiranchem Inc (300082) has total liabilities worth CN¥2.60 Billion CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Liaoning Oxiranchem Inc - Total Liabilities Trend (2007–2024)
This chart illustrates how Liaoning Oxiranchem Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Liaoning Oxiranchem Inc Competitors by Total Liabilities
The table below lists competitors of Liaoning Oxiranchem Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
YCC CORP
KQ:232140
|
Korea | ₩122.69 Billion |
|
SP Group A/S
CO:SPG
|
Denmark | Dkr1.45 Billion |
|
Ripley Corp
SN:RIPLEY
|
Chile | CL$2.89 Trillion |
|
Comba Telecom Systems Holdings Limited
PINK:COBJF
|
USA | $4.73 Billion |
|
Robinsons Land Corporation
PINK:RBLAF
|
USA | $91.98 Billion |
|
Mesa Laboratories Inc
NASDAQ:MLAB
|
USA | $248.16 Million |
|
Farglory Land Development Co Ltd
TW:5522
|
Taiwan | NT$64.70 Billion |
|
Grupo Mateus S.A
SA:GMAT3
|
Brazil | R$12.44 Billion |
Liability Composition Analysis (2007–2024)
This chart breaks down Liaoning Oxiranchem Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.95 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.95 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.47 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Liaoning Oxiranchem Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Liaoning Oxiranchem Inc (2007–2024)
The table below shows the annual total liabilities of Liaoning Oxiranchem Inc from 2007 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥2.74 Billion | +17.05% |
| 2023-12-31 | CN¥2.34 Billion | -19.94% |
| 2022-12-31 | CN¥2.92 Billion | -4.47% |
| 2021-12-31 | CN¥3.06 Billion | +59.14% |
| 2020-12-31 | CN¥1.92 Billion | +31.63% |
| 2019-12-31 | CN¥1.46 Billion | -37.36% |
| 2018-12-31 | CN¥2.33 Billion | -26.16% |
| 2017-12-31 | CN¥3.16 Billion | +28.37% |
| 2016-12-31 | CN¥2.46 Billion | +14.37% |
| 2015-12-31 | CN¥2.15 Billion | +2.80% |
| 2014-12-31 | CN¥2.09 Billion | +136.46% |
| 2013-12-31 | CN¥884.97 Million | +43.16% |
| 2012-12-31 | CN¥618.15 Million | +36.29% |
| 2011-12-31 | CN¥453.56 Million | +57.69% |
| 2010-12-31 | CN¥287.63 Million | -52.71% |
| 2009-12-31 | CN¥608.18 Million | +225.25% |
| 2008-12-31 | CN¥186.99 Million | +19.45% |
| 2007-12-31 | CN¥156.54 Million | -- |